{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:17:27Z","timestamp":1785323847251,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.advms.2015.04.003","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T14:14:16Z","timestamp":1430576056000},"page":"246-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases"],"prefix":"10.1016","volume":"60","author":[{"given":"Dorota","family":"Roszak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miros\u0142awa","family":"Ga\u0142\u0119cka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Cichy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Szachta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2015.04.003_bib0140","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cgh.2007.03.006","article-title":"A critical evaluation of serologic markers for inflammatory bowel disease","volume":"5","author":"Austin","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.advms.2015.04.003_bib0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0016-5085(87)90856-0","article-title":"Colonoscopy in inflamatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score","volume":"92","author":"Pera","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2015.04.003_bib0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.dld.2007.07.165","article-title":"Epidemiology, genes and inflammatory bowel diseases in childhood","volume":"4","author":"de Mesquita","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.advms.2015.04.003_bib0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.dld.2007.07.166","article-title":"Early onset IBD: what's the difference?","volume":"40","author":"Nieuwenhuis","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.advms.2015.04.003_bib0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3748\/wjg.v20.i2.363","article-title":"Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome","volume":"20","author":"D\u00e4britz","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.advms.2015.04.003_bib0165","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2014.154","article-title":"IBD. Faecal calprotectin testing \u2013 the need for better standardization","author":"Burri","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"January (1)","key":"10.1016\/j.advms.2015.04.003_bib0170","first-page":"41","article-title":"Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16\u201350 years","volume":"9","author":"Kennedy","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.advms.2015.04.003_bib0175","first-page":"322","article-title":"The use of fecal calprotectin and lactoferrin in patients with IBD. Review","volume":"76","author":"Stragier","year":"2013","journal-title":"Acta Gastroenterol Belg"},{"issue":"2","key":"10.1016\/j.advms.2015.04.003_bib0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.gtc.2012.01.007","article-title":"Fecal markers: calprotectin and lactoferrin","volume":"41","author":"Abraham","year":"2012","journal-title":"Gastroenterol Clin North Am"},{"issue":"4","key":"10.1016\/j.advms.2015.04.003_bib0185","first-page":"824","article-title":"A study to determine fecal lactoferrin in patients with ulcerative colitis","volume":"90","author":"Sudo","year":"1993","journal-title":"Jpn J Gastroenterol"},{"key":"10.1016\/j.advms.2015.04.003_bib0190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MPG.0b013e3180308d8e","article-title":"Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease","volume":"44","author":"Walker","year":"2007","journal-title":"J Ped Gastroenterol Nutr"},{"key":"10.1016\/j.advms.2015.04.003_bib0195","series-title":"Laktoferyna w kale jako wyk\u0142adnik aktywno\u015bci procesu zapalnego w nieswoistych zapaleniach jelit u dzieci","author":"Borkowska","year":"2008"},{"key":"10.1016\/j.advms.2015.04.003_bib0200","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1365-2036.2007.03457.x","article-title":"Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin","volume":"26","author":"Schr\u00f6der","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.advms.2015.04.003_bib0205","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1007\/s10620-011-1633-y","article-title":"Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease","volume":"56","author":"Aomatsu","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.advms.2015.04.003_bib0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1651-2227.2002.tb01638.x","article-title":"Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children","volume":"91","author":"Olafsdottir","year":"2002","journal-title":"Acta Peadiatr"},{"issue":"3","key":"10.1016\/j.advms.2015.04.003_bib0215","first-page":"167","article-title":"Kliniczne wska\u017aniki w nieswoistych zapaleniach jelit u dzieci","volume":"9","author":"Kobelska-Dubiel","year":"2007","journal-title":"Pediatr Wsp\u00f3\u0142, Hepatol \u017byw Dz"},{"issue":"7765","key":"10.1016\/j.advms.2015.04.003_bib0275","first-page":"188","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis","volume":"341","author":"Van Rheenen","year":"2010","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.advms.2015.04.003_bib0225","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1080\/08035250500254639","article-title":"Faecal calprotectin in children with chronic gastrointestinal symptoms","volume":"94","author":"Bremner","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.advms.2015.04.003_bib0230","first-page":"387","article-title":"Usefulness of plasma tumor M2-pyruvate kinase in the diagnosis of gastrointestinal cancer","volume":"42","author":"Kim","year":"2003","journal-title":"Kor J Gastroenterol"},{"issue":"9","key":"10.1016\/j.advms.2015.04.003_bib0235","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/sj.bjc.6603712","article-title":"Tumour M2-PK as a stool marker for colorectal cancer: Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients","volume":"96","author":"Haug","year":"2007","journal-title":"Br J Cancer."},{"issue":"3","key":"10.1016\/j.advms.2015.04.003_bib0240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MEG.0b013e3280102f78","article-title":"Tumour M2-pyruvate kinase: a gastrointestinal cancer marker","volume":"19","author":"Kumar","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.advms.2015.04.003_bib0245","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/sj.bjc.6602033","article-title":"Faecal tumor M2 pyruvate kinase: a new sensitive screening tool for colorectal cancer","volume":"91","author":"Hardt","year":"2004","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.advms.2015.04.003_bib0250","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/00365520701320513","article-title":"Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease","volume":"42","author":"Czub","year":"2007","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"10.1016\/j.advms.2015.04.003_bib0255","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/ibd.20214","article-title":"Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation","volume":"13","author":"Chung-Faye","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.advms.2015.04.003_bib0260","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/ibd.20946","article-title":"Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders","volume":"15","author":"Jeffery","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.advms.2015.04.003_bib0265","first-page":"99","article-title":"Comparison of fecal pyruvate kinase isoform M2 and calprotectin in assessment of pediatric inflammatory bowel disease severity and activity","volume":"61","author":"Czub","year":"2014","journal-title":"Acta Biochem Pol"},{"issue":"6","key":"10.1016\/j.advms.2015.04.003_bib0270","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1572-0241.2003.07458.x","article-title":"Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation","volume":"98","author":"Kane","year":"2003","journal-title":"Am J Gastroenterol"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112615000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112615000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T09:10:34Z","timestamp":1566637834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112615000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1896112615000243"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2015.04.003","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2015.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Medical University of Bialystok. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}